Key findings included increased IGFBP2 and THBS2 levels in cirrhosis compared to NAFLD and the general population, while ACY1 levels were higher in NAFLD in contrast to the general population. This evidence concerns the gene THBS2 and metabolic dysfunction-associated steatotic liver disease.